U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07190482) titled 'Treatment of Tinnitus With Olanzapine' on Sept. 12.
Brief Summary: This research aims to evaluate the effects of the drug olanzapine on the discomfort caused by tinnitus according to each patient's personality traits. Olanzapine is a drug used as an antipsychotic whose mechanism of action makes it potentially useful for the treatment of tinnitus.
Study Start Date: Oct. 01, 2023
Study Type: INTERVENTIONAL
Condition:
Tinnitus
Tinnitus, Subjective
Intervention:
DRUG: Olanzapine 5 Mg ORAL TABLET
OLANZAPINE ARM
DRUG: Placebo Drug
placebo administered for 8 weeks
Recruitment Status: COMPLETED
Sponsor: University of Sao Paulo
...